Auro-Dri feedback meeting
This article was originally published in The Tan Sheet
Executive Summary
FDA schedules "OTC feedback" meeting with Del Pharmaceuticals on May 27 to discuss clinical trial design issues for Auro-Dri, a product intended to dry water-clogged ears ("The Tan Sheet" March 14, In Brief)